EMEA-001501-PIP04-19-M01
Key facts
Invented name |
Dupixent
|
Active substance |
dupilumab
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0361/2021
|
PIP number |
EMEA-001501-PIP04-19-M01
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of eosinophilic esophagitis
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Regeneron Ireland DAC
Tel. +1 9148 475385 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|